Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of Single and Multiple Ascending Doses of M5542 Administered Subcutaneously in Healthy Participants

Status: Suspended

Phase of Trial: Phase I

Latest Information Update: 07 Oct 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

10 Sep 2025 Planned End Date changed from 15 Dec 2025 to 31 Mar 2028.
10 Sep 2025 Planned primary completion date changed from 15 Dec 2025 to 8 Mar 2027.
15 Jan 2025 Status changed from recruiting to suspended.(Reason the study was stopped: Sponsor decision)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com